BioSpace News Archive

Major Non-Dilutive Financing Deal with Canadian Tier 1 Bank Represents Significant Milestone in the Cannabis Sector

Skyhawk and Celgene enter into a five-year strategic collaboration. Celgene to receive exclusive options to license a number of Skyhawk’s product candidates focused on high-value targets in neurological indications in return for an upfront fee, and potential future license fees, milestone payments, and royalties

Alongside its recently announced strategic collaboration, the Company has closed a new $40 million all-common stock equity investment by its strategic collaborators, major family investors, and leading venture funds

BioClin Therapeutics, Inc., a privately-held clinical stage drug development company developing a first-in-class anti-FGFR3 (fibroblast growth factor receptor 3) monoclonal antibody in areas of high unmet medical need, announced today the appointment of Scott D. Myers as chairman of Board of Directors.

Positive trend vote recommending the approval of the Marketing Authorisation Application (MAA) for neratinib for the extended adjuvant treatment of early stage HER2-positive hormone receptor positive breast cancer.

ProBioGen AG and Nouscom AG, today jointly announced signing a license agreement.

Cardurion Pharmaceuticals is pleased to share the members of its Scientific and Clinical Advisory Boards.

Aerpio will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018

Inthera Bioscience AG today announced that three senior Pharma and Biotech Industry members joined its management team.

Saladax Biomedical Inc, Inc., a diagnostics company providing kits to measure drug blood levels for adherence and medication management, has signed a license agreement with Janssen Pharmaceutical, NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the terms of the agreement Saladax acquired the worldwide exclusive patent rights for diagnostic tests that determine drug levels in patients undergoing treatment with antipsychotic medications.